Format

Send to

Choose Destination
Arch Dermatol. 2001 Mar;137(3):337-41.

Direct medical costs for surgical and medical treatment of condylomata acuminata.

Author information

1
Department of Dermatology, College of Physicians and Surgeons, Columbia University, New York, NY, USA. murad@alam.com

Abstract

OBJECTIVE:

To determine which treatment modalities for condylomata acuminata are associated with the lowest direct medical costs.

DESIGN:

Cost-effectiveness analysis.

SETTING:

Ambulatory private practice, primary or specialty care.

PATIENTS OR OTHER PARTICIPANTS:

Adults with no presenting complaints other than condylomata acuminata.

INTERVENTIONS:

Construction of a cost-effectiveness model. From a literature review, extraction of commonly accepted guidelines regarding duration and frequency as well as reports of efficacies of typical treatment regimens; from Medicare physician fee schedules, costs of physician visits and physician-administered treatments; from published data, average wholesale prices of medications.

MAIN OUTCOME MEASURE:

Estimated direct medical costs per complete clearance associated with different treatment options for condylomata acuminata.

RESULTS:

Mean direct medical costs per complete clearance are lowest for surgical excision ($285). Other low-cost modalities are loop electrosurgical excision procedure ($316), electrodesiccation ($347), carbon dioxide laser ($416), podofilox ($424), and pulsed-dye laser ($479). Higher-cost modalities are cryotherapy ($951), trichloroacetic acid ($986), imiquimod ($1255), podophyllum resin ($1632), and interferon alfa-2b ($6665).

CONCLUSION:

Surgical modalities, including excision, electrodesiccation, loop electrosurgical excision procedure, and laser, as well as podofilox are low-cost options for the treatment of condylomata acuminata.

PMID:
11255335
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center